Nejc Sever

Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission

Jurij Hanžel, Jurij Zdovc, Tina Kurent et al. · Clinical Gastroenterology and Hepatology · 2020 · 51 citations · Full text

Immunology, Gastroenterology, Biochemical Remission +5

Success and safety of high infliximab trough levels in inflammatory bowel disease

David Drobne, Tina Kurent, Saša Golob et al. · Scandinavian Journal of Gastroenterology · 2018 · 46 citations

Comparable Triglyceride Reduction With Plasma Exchange and Insulin in Acute Pancreatitis – A Randomized Trial

Jakob Gubenšek, Milena Andonova, Alexander Jerman et al. · Frontiers in Medicine · 2022 · 43 citations · Full text

Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease

Jurij Hanžel, Nejc Sever, Ivan Ferkolj et al. · United European Gastroenterology Journal · 2019 · 27 citations · Full text

Ustekinumab Dosing Individualization in Crohn’s Disease Guided by a Population Pharmacokinetic–Pharmacodynamic Model

Jurij Zdovc, Jurij Hanžel, Tina Kurent et al. · Pharmaceutics · 2021 · 24 citations · Full text